Browsing: Polycythemia

Treatments

Potential Rusfertide Approval May Offer More Control of Polycythemia Vera

By NewsCancerMarch 19, 20260

The FDA granted priority review to rusfertide as a potential therapy for patients with polycythemia vera in March 2026.1 If…

Treatments

By NewsCancerMarch 14, 20260

In March 2026, the FDA granted priority review to rusfertide as a potential treatment option for patients with polycythemia vera.…

Treatments

By NewsCancerMarch 2, 20260

The FDA has granted priority review to a new drug application (NDA) seeking approval for rusfertide as a treatment for…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.